Movetis
Movetis was a pharmaceutical company that specialized in the development and commercialization of drugs for the treatment of gastrointestinal disorders. The company was known for its innovative approach to addressing unmet medical needs within the gastroenterology field. Movetis aimed to improve the quality of life for patients suffering from various gastrointestinal conditions by providing new and effective treatment options.
History[edit | edit source]
Movetis was established with a focus on identifying, developing, and bringing to market novel therapeutic solutions for gastrointestinal diseases. Throughout its operation, the company worked on a range of products, from development through to commercialization, targeting conditions such as chronic constipation, irritable bowel syndrome, and gastroesophageal reflux disease.
Products[edit | edit source]
One of the notable products developed by Movetis was Resolor (prucalopride), a drug designed to treat chronic constipation in patients who did not respond adequately to standard laxative treatments. Resolor works by stimulating the serotonin receptors in the gut, thereby enhancing bowel motility and improving bowel movements.
Acquisition[edit | edit source]
In a significant development for the company, Movetis was acquired by a larger pharmaceutical entity. This acquisition was part of the larger company's strategy to expand its portfolio in the gastrointestinal therapeutic area. The acquisition allowed for greater resources to be allocated towards the development and distribution of Movetis' products, potentially benefiting a larger patient population.
Impact on Gastrointestinal Therapeutics[edit | edit source]
Movetis' work in the field of gastroenterology represented a significant contribution to the development of new treatments for gastrointestinal disorders. By focusing on areas of unmet medical need, the company played a crucial role in advancing medical knowledge and providing healthcare professionals with additional tools to manage these conditions effectively.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
